In a study of 168 stroke patients, MMP-9 at a concentration > 181.7 ng/mL showed a sensitivity of 82.9%, a specificity of 81.3%, a PPV of 48%, and an NPV of 95.8% in predicting haemorrhagic transformation [51]. This evidence concerns the gene MMP9 and stroke disorder.